Veracyte, Inc. (VCYT)
36.10
-1.64
(-4.35%)
USD |
NASDAQ |
Feb 04, 16:00
36.06
-0.04
(-0.10%)
After-Hours: 20:00
Veracyte EPS Diluted (Quarterly) : 0.2401 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Thermo Fisher Scientific, Inc. | 5.21 |
| FONAR Corp. | 0.3368 |
| XWELL, Inc. | -0.2557 |
| ProPhase Labs, Inc. (DELISTED) | -1.646 |
| Insight Molecular Diagnostics, Inc. | -0.3388 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 19.14M |
| Revenue (Quarterly) | 131.87M |
| Total Expenses (Quarterly) | 112.74M |
| Enterprise Value | 2.528B |
| Gross Profit Margin (Quarterly) | 67.76% |
| Profit Margin (Quarterly) | 14.51% |
| Earnings Yield | 1.05% |
| Operating Earnings Yield | 1.72% |
| Normalized Earnings Yield | 1.635 |